Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade

Transplantation

Volumn 76, Issue 6, 2003, Pages 988-994

  Foster, Robert D ^a   Pham, Si ^b   Li, Sen ^b   Aitouche, Abdelouahab ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN; TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; COMPOSITE GRAFT; CONTROLLED STUDY; GRAFT SURVIVAL; HAND; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; WHOLE BODY RADIATION;

ANIMALS; ANTIGENS, CD28; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; RATS; RATS, INBRED ACI; RATS, INBRED F344; RATS, INBRED WF; T-LYMPHOCYTES; TACROLIMUS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0141433187     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000079827.91675.A3     Document Type: Article

References (21)

1. Wekerle T, Sykes M. Mixed chimerism and transplantation tolerance. Ann Rev Med 2001; 52: 353.
2. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
3. Pearson TC, Alexander DZ, Hendrix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 1996; 61: 997.
4. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad U S A 1997; 94: 8789.
5. Schwartz RH, Fathman CG, Sachs DH. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. J Immunol 1976; 116: 929.
6. Hoffman RA, Langrehr JM, Billiar TR, et al. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990; 145: 2220.
7. Saurat JH, Gluckman E, Bussel A, et al. The lichen planuslike eruption after bone marrow transplantation. Br J Dermatol 1975; 93: 675.
8. Billingham RE. Free skin grafting in mammals. In: RE Billingham, WK Silvers, eds. Transplantation of tissues and cells. Wistar Institute Press, Philadelphia 1961.
9. Li S, Thanikachalam M, Pang M, et al. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. Exp Hematol 2001; 29: 534.
10. Foster RD, Fan L, Neipp M, et al. donor-specific tolerance induction in composite tissue allografts. Am J Surg 1998; 176: 418.
11. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464.
12. Gammie JS, Li S, Colson YL, et al. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol 1998; 26: 927.
13. Colson YL, Li H, Boggs SS, et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 1996; 157: 2820.
14. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827.
15. Blazar BR, Taylor PA, Fitzsimmons WE, et al. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. J Immunol 1994; 153: 1836.
16. Pugh-Humphreys RG, Ross CS, Thompson AW. The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. Immunology 1990; 70: 398.
17. Gurevitch O, Prigozhina TB, Pugatsch T, et al. Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment. Transplantation 1999; 68: 1362.
18. Bingaman AW, Waitze SY, Alexander DZ, et al. Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning. Transplantation 2000; 69: 2491.
19. Wu DY, Goldschneider I. Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. J Immunol 1999; 162: 6926.
20. Cooper MH, Hartman GG, Starzl TE, et al. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991; 23: 3234.
21. Hale DA, Gottschalk R, Umemura A, et al. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 2000; 69: 1242.